David Gilot
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 5%
Papers in
-
- Liver physiology and pathology 8
-
- RNA Interference and Gene Delivery 5
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 5
- Melanoma and MAPK Pathways 5
- Genomics, phytochemicals, and oxidative stress 4
- Co-authors
- Olivier Fardel (14 shared papers)Christiane Guguen‐Guillouzo (9 shared papers)Marie‐Dominique Galibert (11 shared papers)Dominique Lagadic‐Gossmann (12 shared papers)Pascal Loyer (8 shared papers)Eric Le Ferrec (5 shared papers)Laura Bachelot (7 shared papers)Valérie Lecureur (5 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Biochemical and Biophysical Research Communications (4 papers)Toxicology Letters (2 papers)Cancers (2 papers)PLoS ONE (2 papers)
- Partner nations
- FranceAustraliaUnited States
In The Last Decade
David Gilot
60 papers receiving 3.0k citations
David Gilot's Hit Papers
Peers
Comparison fields: 5 of 117
- Biological Psychiatry 327
- Behavioral Neuroscience 110
- Hepatology 222
- Cancer Research 409
- Health, Toxicology and Mutagenesis 388
Countries citing papers authored by David Gilot
This map shows the geographic impact of David Gilot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gilot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gilot more than expected).
Fields of papers citing papers by David Gilot
This network shows the impact of papers produced by David Gilot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gilot. The network helps show where David Gilot may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gilot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aryl hydrocarbon receptor control of a disease tolerance defence pathway Hit paper breakdown → | 2014 | 608 |
| 2 | 2020 | 225 | |
| 3 | 2002 | 221 | |
| 4 | 2008 | 121 | |
| 5 | 2002 | 117 | |
| 6 | 2005 | 105 | |
| 7 | 2002 | 100 | |
| 8 | 2006 | 98 | |
| 9 | 2003 | 96 | |
| 10 | 2018 | 87 | |
| 11 | 2017 | 81 | |
| 12 | 2014 | 74 | |
| 13 | 2021 | 67 | |
| 14 | 2011 | 60 | |
| 15 | 2003 | 60 | |
| 16 | 2007 | 58 | |
| 17 | 2004 | 56 | |
| 18 | 2005 | 46 | |
| 19 | 2002 | 44 | |
| 20 | 2010 | 42 |
About David Gilot
David Gilot is a scholar working on Hepatology, Molecular Biology, Cancer Research, Health, Toxicology and Mutagenesis and Biological Psychiatry, having authored 61 papers that have together received 3.1k indexed citations. Recurring topics across this work include Toxic Organic Pollutants Impact (9 papers), Liver physiology and pathology (8 papers), RNA Interference and Gene Delivery (5 papers), RNA modifications and cancer (5 papers), CRISPR and Genetic Engineering (5 papers), Melanoma and MAPK Pathways (5 papers), Cancer-related Molecular Pathways (4 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Biological Psychiatry (327 citations), Behavioral Neuroscience (110 citations), Hepatology (222 citations), Cancer Research (409 citations) and Health, Toxicology and Mutagenesis (388 citations). David Gilot has collaborated with scholars based in France, Australia and United States. Frequent co-authors include Olivier Fardel, Christiane Guguen‐Guillouzo, Marie‐Dominique Galibert, Dominique Lagadic‐Gossmann, Pascal Loyer, Eric Le Ferrec, Laura Bachelot, Valérie Lecureur, Georges Baffet and Anaïs M. Quéméner. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Toxicology Letters, Cancers and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.